SignatureFD’s AIM ImmunoTech AIM Stock Holding History

SignatureFD’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5	Closed	-$1K	–	2773
2020 Q1	$1K	Buy	+5	New	+$784	﹤0.01%	2267

Other funds holding AIM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SWM

SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

SAMH

Shanda Asset Management Holdings Tortola,, British Virgin Islands $1.85B AUM 36.09% 1-Year Est. Return

SignatureFD's AIM Position: Q2 2020 in Review

SignatureFD sold out of AIM ImmunoTech (AIM) in Q2 2020, closing a stake of 5 shares — an estimated $1K sold.

SignatureFD first reported a position in AIM in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 22 funds tracked by Wall St. Rank hold AIM as of Q2 2020.

SignatureFD reported no remaining AIM ImmunoTech position as of Q2 2020 after selling out during the quarter.
SignatureFD sold 5 AIM ImmunoTech shares in Q2 2020, an estimated $1K.
SignatureFD first reported a position in AIM ImmunoTech in Q1 2020 and held it in 1 quarter.
SignatureFD's AIM ImmunoTech position peaked at $1K in Q1 2020.
22 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2020.

Based on SignatureFD's 13F filing for Q2 2020, filed 30 Jul 2020.